ea0081p417 | Pituitary and Neuroendocrinology | ECE2022
Pla Peris Begona
, Castro de la Vega Iciar
, Roxana Padilla Segura Mayet
, Serisuelo Meneu Esther
, Abellan Galiana Pablo
, Maravall Javier
, Perez Naranjo Susana
, Gonzalez Boillos Margarita
, Angel Merchante Alfaro Agustin
Introduction: Terlipressin is a non-selective vasopressin analogue used in patients with decompensated cirrhosis, gastrointestinal haemorrhage or hepatorenal syndrome. It directly binds to V1 receptors improving circulatory volume by causing splanchnic vasoconstriction and portal hypertension inhibition, and has a full V2 receptor agonism in the collecting duct. In consequence, it increases reabsorption of water and can lead to a decrease in plasma osmolality and hyponatremia....